Clinical management of urticaria using omalizumab: The first licensed biological therapy available for chronic spontaneous urticaria

A. M. Giménez-Arnau, E. Toubi, A. M. Marsland, M. Maurer

Research output: Contribution to journalReview articleResearchpeer-review

39 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical management of urticaria using omalizumab: The first licensed biological therapy available for chronic spontaneous urticaria'. Together they form a unique fingerprint.

Medicine & Life Sciences